Manzoli L - Search Results

1

Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells.

Darici S, Zavatti M, Braglia L, Accordi B, Serafin V, Horne GA, Manzoli L, Palumbo C, Huang X, Jørgensen HG, Marmiroli S. Darici S, et al. Among authors: manzoli l. Adv Biol Regul. 2021 Dec;82:100830. doi: 10.1016/j.jbior.2021.100830. Epub 2021 Sep 17. Adv Biol Regul. 2021. PMID: 34555701

2

Nuclear PLCbeta(1) acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells.

Faenza I, Matteucci A, Bavelloni A, Marmiroli S, Martelli AM, Gilmour RS, Suh PG, Manzoli L, Cocco L. Faenza I, et al. Among authors: manzoli l. Biochim Biophys Acta. 2002 May 8;1589(3):305-10. doi: 10.1016/s0167-4889(02)00192-1. Biochim Biophys Acta. 2002. PMID: 12031797 Free article.

3

Ankrd2/ARPP is a novel Akt2 specific substrate and regulates myogenic differentiation upon cellular exposure to H(2)O(2).

Cenni V, Bavelloni A, Beretti F, Tagliavini F, Manzoli L, Lattanzi G, Maraldi NM, Cocco L, Marmiroli S. Cenni V, et al. Among authors: manzoli l. Mol Biol Cell. 2011 Aug 15;22(16):2946-56. doi: 10.1091/mbc.E10-11-0928. Epub 2011 Jul 7. Mol Biol Cell. 2011. PMID: 21737686 Free PMC article.

4

PLC and PI3K/Akt/mTOR signalling in disease and cancer.

Follo MY, Manzoli L, Poli A, McCubrey JA, Cocco L. Follo MY, et al. Among authors: manzoli l. Adv Biol Regul. 2015 Jan;57:10-6. doi: 10.1016/j.jbior.2014.10.004. Epub 2014 Nov 26. Adv Biol Regul. 2015. PMID: 25482988 Review.

5

Exploring the controversial role of PI3K signalling in CD4⁺ regulatory T (T-Reg) cells.

Poli A, Fiume R, Mongiorgi S, Zaurito A, Sheth B, Vidalle MC, Hamid SA, Kimber S, Campagnoli F, Ratti S, Rusciano I, Faenza I, Manzoli L, Divecha N. Poli A, et al. Among authors: manzoli l. Adv Biol Regul. 2020 May;76:100722. doi: 10.1016/j.jbior.2020.100722. Epub 2020 Apr 23. Adv Biol Regul. 2020. PMID: 32362560 Review.

6

Therapeutic resistance in breast cancer cells can result from deregulated EGFR signaling.

Steelman LS, Chappell WH, Akula SM, Abrams SL, Cocco L, Manzoli L, Ratti S, Martelli AM, Montalto G, Cervello M, Libra M, Candido S, McCubrey JA. Steelman LS, et al. Among authors: manzoli l. Adv Biol Regul. 2020 Dec;78:100758. doi: 10.1016/j.jbior.2020.100758. Epub 2020 Sep 28. Adv Biol Regul. 2020. PMID: 33022466 Review.

7

Advances in MDS/AML and inositide signalling.

De Stefano A, Marvi MV, Fazio A, McCubrey JA, Suh PG, Ratti S, Ramazzotti G, Manzoli L, Cocco L, Follo MY. De Stefano A, et al. Among authors: manzoli l. Adv Biol Regul. 2023 Jan;87:100955. doi: 10.1016/j.jbior.2023.100955. Epub 2023 Jan 21. Adv Biol Regul. 2023. PMID: 36706610 Free article.

8

Nuclear phospholipase C beta1, regulation of the cell cycle and progression of acute myeloid leukemia.

Cocco L, Manzoli L, Palka G, Martelli AM. Cocco L, et al. Among authors: manzoli l. Adv Enzyme Regul. 2005;45:126-35. doi: 10.1016/j.advenzreg.2005.02.001. Epub 2005 Jul 18. Adv Enzyme Regul. 2005. PMID: 16024064

9

Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes.

Cocco L, Faenza I, Follo MY, Ramazzotti G, Gaboardi GC, Billi AM, Martelli AM, Manzoli L. Cocco L, et al. Among authors: manzoli l. Adv Enzyme Regul. 2008;48:2-9. doi: 10.1016/j.advenzreg.2007.11.013. Epub 2008 Mar 17. Adv Enzyme Regul. 2008. PMID: 18280812 Review. No abstract available.

10

Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology.

Cocco L, Faenza I, Follo MY, Billi AM, Ramazzotti G, Papa V, Martelli AM, Manzoli L. Cocco L, et al. Among authors: manzoli l. Adv Enzyme Regul. 2009;49(1):2-10. doi: 10.1016/j.advenzreg.2008.12.001. Epub 2008 Dec 31. Adv Enzyme Regul. 2009. PMID: 19159640 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

412 results

Search Page